effectiveness (VE) measures in an integrated platform of influenza monitoring, described here for the 2013–2014 influenza season of resurgent A(H1N1)pdm09 and late-season type B activity. Methods. VE was estimated as [1 − odds ratio] × 100 % and compared vaccination status between individuals who tested positive (cases) and those who tested negative (controls) for influenza virus. Vaccine-virus relatedness was assessed by genomic sequence analysis and hemagglutination inhibition assays
Estimations of the effectiveness of vaccines against seasonal influenza virus are guided by comparis...
The effectiveness of currently licensed vaccines against influenza has not been clearly established,...
The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to s...
effectiveness (VE) measures in an integrated platform of influenza monitoring, described here for th...
Objectives. To estimate influenza vaccine effectiveness (VE) for the 2007–2008 season and assess the...
Objectives. To estimate influenza vaccine effectiveness (VE) for the 2007–2008 season and assess the...
Background. Influenza vaccines may be reformulated annually because of antigenic drift in influenza ...
AbstractBackgroundInfluenza vaccines are now widely used to reduce the burden of annual epidemics of...
In the first five I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) influenza seasons va...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
In the first five I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) influenza seasons va...
Regarding the wide genetic and antigenic variability of influenza viruses, overall or subtype influe...
The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to s...
After the influenza H1N1 pandemic of 2009, the seasonal A/Brisbane/59/2007 strain was replaced by th...
The effectiveness of currently licensed vaccines against influenza has not been clearly established,...
Estimations of the effectiveness of vaccines against seasonal influenza virus are guided by comparis...
The effectiveness of currently licensed vaccines against influenza has not been clearly established,...
The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to s...
effectiveness (VE) measures in an integrated platform of influenza monitoring, described here for th...
Objectives. To estimate influenza vaccine effectiveness (VE) for the 2007–2008 season and assess the...
Objectives. To estimate influenza vaccine effectiveness (VE) for the 2007–2008 season and assess the...
Background. Influenza vaccines may be reformulated annually because of antigenic drift in influenza ...
AbstractBackgroundInfluenza vaccines are now widely used to reduce the burden of annual epidemics of...
In the first five I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) influenza seasons va...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
In the first five I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) influenza seasons va...
Regarding the wide genetic and antigenic variability of influenza viruses, overall or subtype influe...
The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to s...
After the influenza H1N1 pandemic of 2009, the seasonal A/Brisbane/59/2007 strain was replaced by th...
The effectiveness of currently licensed vaccines against influenza has not been clearly established,...
Estimations of the effectiveness of vaccines against seasonal influenza virus are guided by comparis...
The effectiveness of currently licensed vaccines against influenza has not been clearly established,...
The 2009 influenza A(H1N1)pdm09 pandemic highlighted the need for improved scientific knowledge to s...